MannKind Corp. (MNKD)

[parkerstar]

Really? Where? I looked all over and couldn't find it! Of course, it was difficut reading with that HUGE purple bad across the bottom WARNING about BRONCHOSPASM and the NEED for a LUNG test!

Then again, it doesn't really matter when you consider that fiasp has been calling itself "ultrafast" for over TWO YEARS:

https://www.medscape.com/viewarticle/877892

...so I imagine any EFFECT will be NIL! Indeed, wanna see something HILATIOUS:

"Sales of Fiasp, the novel mealtime fastacting insulin aspart, reached DKK 590 million. Fiasp has now been launched in 25 countries"

That was for the year 2018 -- a YEAR after fiasp was launched! 590 DKK equals 87 MILLION dollars! Remind us again how much revenue afizzle is expecting THIS year, almost FIVE YEARS after it was launched!